Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sablich Kim
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-06
Sale
2022-06-08
4:56 pm
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
3,829$151.45$579,89824,754
(Direct)
View
2021-11-11
Sale
2021-11-15
7:30 pm
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
2,748$135.01$371,00021,135
(Direct)
View
2020-03-18
Sale
2020-03-19
4:32 pm
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
785$7.3714$5,78758,905
(Direct)
View
2020-01-15
Sale
2020-01-16
5:28 pm
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
4,840$14.04$67,95459,690
(Direct)
View
2019-12-18
Sale
2019-12-19
4:25 pm
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
2,585$16.22$41,92964,530
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-06
Tax Withholding
2022-06-08
4:56 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
1,759$149.2524,754
(Direct)
View
2022-03-11
Option Award
2022-03-11
9:06 pm
N/A
2032-03-10
Eiger BioPharmaceuticals Inc.EIGRSablich Kim
Director
18,000$018,000
(Direct)
View
2022-03-03
Option Award
2022-03-09
6:05 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
9,953$030,342
(Direct)
View
2022-03-03
Tax Withholding
2022-03-09
6:05 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
746$153.9630,342
(Direct)
View
2021-06-05
Tax Withholding
2021-06-09
6:55 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
1,452$176.4723,883
(Direct)
View
2021-04-23
Option Award
2021-04-23
5:35 pm
N/A
2031-04-22
Eiger BioPharmaceuticals Inc.EIGRSablich Kim
Director
25,000$025,000
(Direct)
View
2021-02-25
Option Award
2021-03-01
6:17 pm
N/A
N/A
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
8,535$025,335
(Direct)
View
2020-08-06
Option Award
2020-08-07
7:26 pm
N/A
2030-08-05
Jazz Pharmaceuticals plcJAZZSablich Kim
EVP & GM North America
58,800$058,800
(Direct)
View
2020-04-03
Option Award
2020-04-07
5:14 pm
N/A
2030-04-02
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
222,269$0281,174
(Direct)
View
2019-08-26
Option Award
2019-08-27
4:59 pm
N/A
2028-12-16
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
237,045$0266,745
(Direct)
View
2019-08-26
Disposition
2019-08-27
4:59 pm
N/A
2028-12-16
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
199,630$0266,745
(Direct)
View
2019-04-05
Option Award
2019-04-09
6:23 pm
N/A
2029-05-04
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
66,130$066,130
(Direct)
View
2018-12-17
Option Award
2018-12-18
5:15 pm
N/A
2028-12-16
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
163,200$0163,200
(Direct)
View
2018-12-01
Ownership
2018-12-03
5:04 pm
N/A
N/A
Myovant Sciences Ltd.MYOVSablich Kim
Chief Commercial Officer
0$00
(Direct)
View